Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Regeneron Pharmaceuticals Revenue 2006-2020 | REGN

For a detailed definition, formula and example for Revenue, check out our new background page here.
Regeneron Pharmaceuticals annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Regeneron Pharmaceuticals revenue for the quarter ending September 30, 2020 was $2.294B, a 31.56% increase year-over-year.
  • Regeneron Pharmaceuticals revenue for the twelve months ending September 30, 2020 was $9.244B, a 39.59% increase year-over-year.
  • Regeneron Pharmaceuticals annual revenue for 2019 was $7.863B, a 17.18% increase from 2018.
  • Regeneron Pharmaceuticals annual revenue for 2018 was $6.711B, a 14.28% increase from 2017.
  • Regeneron Pharmaceuticals annual revenue for 2017 was $5.872B, a 20.82% increase from 2016.
  
Regeneron Pharmaceuticals Annual Revenue
(Millions of US $)
2019 $7,863
2018 $6,711
2017 $5,872
2016 $4,860
2015 $4,104
2014 $2,820
2013 $2,105
2012 $1,378
2011 $446
2010 $459
2009 $379
2008 $238
2007 $125
2006 $63
2005 $66
Regeneron Pharmaceuticals Quarterly Revenue
(Millions of US $)
2020-09-30 $2,294
2020-06-30 $1,952
2020-03-31 $1,828
2019-12-31 $3,169
2019-09-30 $1,744
2019-06-30 $1,578
2019-03-31 $1,373
2018-12-31 $1,928
2018-09-30 $1,664
2018-06-30 $1,608
2018-03-31 $1,512
2017-12-31 $1,582
2017-09-30 $1,501
2017-06-30 $1,470
2017-03-31 $1,319
2016-12-31 $1,227
2016-09-30 $1,220
2016-06-30 $1,213
2016-03-31 $1,201
2015-12-31 $1,098
2015-09-30 $1,137
2015-06-30 $999
2015-03-31 $870
2014-12-31 $802
2014-09-30 $726
2014-06-30 $666
2014-03-31 $626
2013-12-31 $610
2013-09-30 $597
2013-06-30 $458
2013-03-31 $440
2012-12-31 $415
2012-09-30 $428
2012-06-30 $304
2012-03-31 $232
2011-12-31 $123
2011-09-30 $103
2011-06-30 $108
2011-03-31 $112
2010-12-31 $134
2010-09-30 $106
2010-06-30 $116
2010-03-31 $104
2009-12-31 $97
2009-09-30 $117
2009-06-30 $90
2009-03-31 $75
2008-12-31 $56
2008-09-30 $66
2008-06-30 $61
2008-03-31 $56
2007-12-31 $65
2007-09-30 $22
2007-06-30 $22
2007-03-31 $16
2006-12-31 $10
2006-09-30 $16
2006-06-30 $19
2006-03-31 $18
2005-12-31 $17
2005-09-30 $16
2005-06-30 $16
2005-03-31 $16
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $57.385B $7.863B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.580B 15.43
Bristol Myers Squibb (BMY) United States $146.079B 10.41
CSL (CSLLY) Australia $96.828B 0.00
Gilead Sciences (GILD) United States $83.911B 11.16
Vertex Pharmaceuticals (VRTX) United States $61.782B 28.73
Illumina (ILMN) United States $59.313B 81.58
Moderna (MRNA) United States $51.846B 0.00
Biogen (BIIB) United States $41.462B 7.37
Alexion Pharmaceuticals (ALXN) United States $34.956B 13.93
BeiGene (BGNE) Cayman Islands $34.150B 0.00
Seagen (SGEN) United States $33.059B 87.02
Genmab (GMAB) Denmark $28.224B 33.38
Genmab (GNMSF) Denmark $26.832B 6.18
BioNTech SE (BNTX) Germany $24.536B 0.00
Exact Sciences (EXAS) United States $22.564B 0.00
Incyte (INCY) United States $21.438B 0.00
Alnylam Pharmaceuticals (ALNY) United States $20.027B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.449B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.603B 66.75
Horizon Therapeutics Public (HZNP) Ireland $17.156B 24.52
Guardant Health (GH) United States $15.988B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.973B 106.01
ARGENX SE-ADR (ARGX) Netherlands $14.722B 0.00
Bio-Techne Corp (TECH) United States $13.768B 88.05
CRISPR Therapeutics AG (CRSP) Switzerland $13.422B 0.00
QIAGEN (QGEN) Netherlands $12.374B 27.86
Repligen (RGEN) United States $11.540B 163.67
Mirati Therapeutics (MRTX) United States $10.783B 0.00
Denali Therapeutics (DNLI) United States $9.489B 0.00
Twist Bioscience (TWST) United States $9.268B 0.00
Adaptive Biotechnologies (ADPT) United States $9.265B 0.00
Ascendis Pharma (ASND) Denmark $8.582B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.575B 0.00
Fate Therapeutics (FATE) United States $8.479B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.399B 0.00
Novavax (NVAX) United States $8.084B 0.00
Sarepta Therapeutics (SRPT) United States $7.752B 0.00
Acceleron Pharma (XLRN) United States $7.508B 0.00
Galapagos (GLPG) Belgium $7.273B 0.00
Exelixis (EXEL) United States $6.869B 46.13
Halozyme Therapeutics (HALO) United States $6.692B 309.38
NeoGenomics (NEO) United States $6.221B 1867.67
SWEDISH ORP BIO (BIOVF) Sweden $6.009B 17.57
Beam Therapeutics (BEAM) United States $5.768B 0.00
Certara (CERT) United States $5.711B 0.00
Emergent Biosolutions (EBS) United States $5.677B 18.63
Blueprint Medicines (BPMC) United States $5.649B 18.70
Amicus Therapeutics (FOLD) United States $5.496B 0.00
Vir Biotechnology (VIR) United States $5.163B 0.00
Eidos Therapeutics (EIDX) United States $4.993B 0.00
China Biologic Products (CBPO) China $4.655B 30.17
Arena Pharmaceuticals (ARNA) United States $4.518B 0.00
Intellia Therapeutics (NTLA) United States $4.393B 0.00
Insmed (INSM) United States $4.278B 0.00
Editas Medicine (EDIT) United States $4.122B 0.00
Arvinas (ARVN) United States $4.071B 0.00
Reata Pharmaceuticals (RETA) United States $3.868B 0.00
MorphoSys AG (MOR) Germany $3.867B 139.95
Legend Biotech (LEGN) United States $3.535B 0.00
Alkermes (ALKS) Ireland $3.532B 34.67
I-Mab (IMAB) China $3.152B 0.00
Bluebird Bio (BLUE) United States $3.096B 0.00
Global Blood Therapeutics (GBT) United States $2.945B 0.00
Intra-Cellular Therapies (ITCI) United States $2.671B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.662B 0.00
Amarin (AMRN) Ireland $2.561B 0.00
Sorrento Therapeutics (SRNE) United States $2.535B 0.00
Arcus Biosciences (RCUS) United States $2.494B 0.00
Zymeworks (ZYME) Canada $2.390B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.298B 0.00
Ligand Pharmaceuticals (LGND) United States $2.294B 59.42
Seres Therapeutics (MCRB) United States $2.195B 0.00
Sangamo Therapeutics (SGMO) United States $2.115B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Myriad Genetics (MYGN) United States $2.003B 0.00
NGM Biopharmaceuticals (NGM) United States $1.974B 0.00
PHARMA MAR SA (PHMMF) Spain $1.959B 0.00
Scholar Rock Holding (SRRK) United States $1.933B 0.00
Viela Bio (VIE) United States $1.912B 0.00
Revance Therapeutics (RVNC) United States $1.903B 0.00
Genetron Holdings (GTH) China $1.875B 0.00
NantKwest (NK) United States $1.873B 0.00
Vericel (VCEL) United States $1.873B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.849B 0.00
UniQure (QURE) Netherlands $1.747B 0.00
Precigen (PGEN) United States $1.708B 0.00
Inovio Pharmaceuticals (INO) United States $1.682B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.658B 0.00
REGENXBIO (RGNX) United States $1.619B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.604B 0.00
Castle Biosciences (CSTL) United States $1.596B 0.00
Heska (HSKA) United States $1.564B 0.00
Codexis (CDXS) United States $1.539B 0.00
Bionano Genomics (BNGO) United States $1.501B 0.00
Zealand Pharma (ZEAL) Denmark $1.480B 0.00
Cytokineticsorporated (CYTK) United States $1.441B 0.00
Travere Therapeutics (TVTX) United States $1.413B 0.00
Mersana Therapeutics (MRSN) United States $1.358B 0.00
Zealand Pharma (ZLDPF) Denmark $1.343B 0.00
Cellectis S.A (CLLS) France $1.329B 0.00
Coherus BioSciences (CHRS) United States $1.321B 8.73
Alector (ALEC) United States $1.315B 0.00
Frequency Therapeutics (FREQ) United States $1.307B 0.00
Adverum Biotechnologies (ADVM) United States $1.305B 0.00
Antibe Therapeutics (ATBPF) Canada $1.227B 0.00
Northwest Biotherapeutics (NWBO) United States $1.195B 0.00
Epizyme (EPZM) United States $1.163B 0.00
Athenex (ATNX) United States $1.156B 0.00
Mesoblast (MESO) Australia $1.087B 0.00
Sutro Biopharma (STRO) United States $1.063B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.031B 0.00
Gritstone Oncology (GRTS) United States $1.024B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.992B 0.00
MiMedx (MDXG) United States $0.986B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.972B 0.00
Morphic Holding (MORF) United States $0.971B 0.00
Cara Therapeutics (CARA) United States $0.954B 0.00
Pliant Therapeutics (PLRX) United States $0.940B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 24.17
Merus (MRUS) Netherlands $0.860B 0.00
Compugen (CGEN) Israel $0.858B 0.00
Protagonist Therapeutics (PTGX) United States $0.855B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.827B 0.00
Kadmon Holdings (KDMN) United States $0.827B 0.00
MannKind (MNKD) United States $0.823B 0.00
Avid Bioservices (CDMO) United States $0.808B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.778B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.777B 39.44
VBI Vaccines (VBIV) United States $0.746B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.729B 0.00
Celldex Therapeutics (CLDX) United States $0.704B 0.00
AnaptysBio (ANAB) United States $0.698B 0.00
Precision BioSciences (DTIL) United States $0.697B 0.00
Syros Pharmaceuticals (SYRS) United States $0.685B 0.00
AquaBounty Technologies (AQB) United States $0.670B 0.00
ALBIREO PHARMA (ALBO) United States $0.669B 0.00
Agenus (AGEN) United States $0.654B 0.00
DBV Technologies S.A (DBVT) France $0.651B 0.00
Curis (CRIS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
MeiraGTx Holdings (MGTX) United States $0.600B 0.00
Clovis Oncology (CLVS) United States $0.590B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.579B 0.00
Affimed (AFMD) Germany $0.576B 0.00
Dynavax Technologies (DVAX) United States $0.575B 0.00
Cel-Sci (CVM) United States $0.567B 0.00
Five Prime Therapeutics (FPRX) United States $0.563B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.559B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.559B 0.00
Anika Therapeutics (ANIK) United States $0.554B 74.92
Prothena (PRTA) Ireland $0.543B 0.00
Geron (GERN) United States $0.537B 0.00
Pandion Therapeutics (PAND) United States $0.535B 0.00
Spero Therapeutics (SPRO) United States $0.511B 0.00
FORTE BIOSCIENC (FBRX) United States $0.500B 0.00
WAVE Life Sciences (WVE) Singapore $0.486B 0.00
Amryt Pharma (AMYT) United Kingdom $0.478B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.475B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.474B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.458B 0.00
AC Immune SA (ACIU) Switzerland $0.454B 0.00
Starpharma Holdings (SPHRY) Australia $0.454B 0.00
Puma Biotechnology (PBYI) United States $0.443B 0.00
UROGEN PHARMA (URGN) United States $0.439B 0.00
XOMA (XOMA) United States $0.433B 0.00
Cue Biopharma (CUE) United States $0.426B 0.00
BioDelivery Sciences (BDSI) United States $0.419B 19.71
Kala Pharmaceuticals (KALA) United States $0.417B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.399B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.09
Cardiff Oncology (CRDF) United States $0.385B 0.00
Athersys (ATHX) United States $0.384B 0.00
NextCure (NXTC) United States $0.375B 0.00
Verastem (VSTM) United States $0.374B 0.00
Selecta Biosciences (SELB) United States $0.372B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
Innate Pharma S.A (IPHA) France $0.355B 0.00
Trevena (TRVN) United States $0.347B 0.00
Arbutus Biopharma (ABUS) United States $0.344B 0.00
AMMO (POWW) United States $0.342B 0.00
Voyager Therapeutics (VYGR) United States $0.339B 8.69
Fortress Biotech (FBIO) United States $0.332B 0.00
IBio (IBIO) United States $0.321B 0.00
Kamada (KMDA) Israel $0.309B 14.48
CytomX Therapeutics (CTMX) United States $0.307B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.304B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Bellus Health (BLU) Canada $0.301B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
HOOKIPA Pharma (HOOK) United States $0.279B 0.00
OSMOTICA PHARM (OSMT) United States $0.279B 0.00
CorMedix Inc (CRMD) United States $0.278B 0.00
Cerecor (CERC) United States $0.262B 0.00
Aptinyx (APTX) United States $0.253B 0.00
Palatin Technologies (PTN) United States $0.246B 0.00
Checkpoint Therapeutics (CKPT) United States $0.246B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.230B 0.00
Eton Pharmaceuticals (ETON) United States $0.224B 0.00
Cogent Biosciences (COGT) United States $0.222B 0.00
VolitionRX (VNRX) United States $0.215B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
TELA Bio (TELA) United States $0.214B 0.00
Idera Pharmaceuticals (IDRA) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.209B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Exicure (XCUR) United States $0.204B 0.00
Strongbridge Biopharma (SBBP) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Kindred Biosciences (KIN) United States $0.195B 0.00
Pluristem Therapeutics (PSTI) Israel $0.194B 0.00
Biofrontera AG (BFRA) Germany $0.191B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.185B 0.00
Clearside Biomedical (CLSD) United States $0.183B 0.00
Nicox SA (NICXF) France $0.182B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.180B 0.00
Oncobiologics (OTLK) United States $0.169B 0.00
DiaMedica Therapeutics (DMAC) United States $0.167B 0.00
VTv Therapeutics (VTVT) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Lumos Pharma (LUMO) United States $0.159B 0.00
Evogene (EVGN) Israel $0.158B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.155B 0.00
Orgenesis (ORGS) United States $0.154B 318.00
Protalix BioTherapeutics (PLX) Israel $0.153B 0.00
Prometic Life Sciences (LMNL) Canada $0.152B 0.00
Catalyst Biosciences (CBIO) United States $0.152B 0.00
Aptevo Therapeutics (APVO) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.147B 0.00
TRACON Pharmaceuticals (TCON) United States $0.145B 0.00
Cocrystal Pharma (COCP) United States $0.145B 0.00
Synlogic (SYBX) United States $0.142B 0.00
Seelos Therapeutics (SEEL) United States $0.138B 0.00
Ecology Coatings (ABVC) United States $0.129B 0.00
Vascular Biogenics (VBLT) Israel $0.129B 0.00
PHASEBIO PHARMA (PHAS) United States $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Prima BioMed (IMMP) Australia $0.125B 0.00
Applied Genetic Technologies (AGTC) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
Celyad SA (CYAD) Belgium $0.116B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.110B 0.00
Aytu Bioscience (AYTU) United States $0.105B 0.00
Organovo Holdings (ONVO) United States $0.102B 0.00
Novogen (KZIA) Australia $0.099B 0.00
Stealth BioTherapeutics (MITO) United States $0.094B 44.75
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Windtree Therapeutics (WINT) United States $0.092B 0.00
Adocia (ADOCY) France $0.091B 0.00
CytRx (CYTR) United States $0.089B 0.00
CollPlant Holdings (CLGN) Israel $0.083B 0.00
Genetic Technologies (GENE) Australia $0.075B 0.00
Purple Biotech (PPBT) Israel $0.072B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.070B 0.00
ARIDIS PHARMACT (ARDS) United States $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Acorda Therapeutics (ACOR) United States $0.061B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.060B 0.00
Vaccinex (VCNX) United States $0.057B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.055B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.055B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Soligenix (SNGX) United States $0.054B 0.00
BioCardia (BCDA) United States $0.053B 0.00
Cleveland BioLabs (CBLI) United States $0.053B 0.00
Yumanity Therapeutics (YMTX) United States $0.052B 0.00
Celsion (CLSN) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Advaxis (ADXS) United States $0.049B 0.00
Chanticleer Holdings (SONN) United States $0.047B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
Spherix (AIKI) United States $0.043B 0.00
Prana Biotechnology (ATHE) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Neuralstem (SNCA) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Lexaria Bioscience (LEXX) Canada $0.022B 0.00
Cesca Therapeutics (THMO) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00